HealthcareNews

Global Epigenetics-Based Instruments Market Size, Share, Forecast Report Offers Accurate Insights till 2026|Pacific Biosciences of California, Inc.; 10x Genomics; Illumina, Inc.; Merck KGaA; QIAGEN; Eisai Co., Ltd.; Novartis AG

Global epigenetics-based instruments market is expected to register a substantial CAGR in the forecast period of 2019-2026. The report contains data from the base year of 2018 and the historic year of 2017. This rise in market value can be attributed to the various innovations and advancements of technologies associated with epigenetics.

Objective of the Report

  1. To analyze strategies/developments such as collaborations, agreements, partnerships, mergers and acquisitions, and product launches and developments in the Epigenetics-Based Instruments market.
  2. Facilitate decision making on the basis of strong historic and forecast of Epigenetics-Based Instruments Market.
  3. Porter’s five forces analysis illustrates the potency of buyers & suppliers that operate in the industry.
  4. Historical, current and projected market size in terms of volume and value. 
  5. The quantitative analysis of the global market from 2019 to 2026 has been provided to determine the market potential.

Get Sample Copy Of This Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-epigenetics-based-instruments-market

Few of the major competitors currently working in the global epigenetics-based instruments market are Pacific Biosciences of California, Inc.; 10x Genomics; Illumina, Inc.; Merck KGaA; QIAGEN; Eisai Co., Ltd.; Novartis AG; Diagenode s.a.; Zymo Research; Active Motif, Inc.; Thermo Fisher Scientific Inc.; Agilent Technologies, Inc.; Bio-Rad Laboratories, Inc.; Bio-Techne among others.

Key Developments in the Market:

  • In April 2019, Pacific Biosciences of California, Inc. announced the launch of “Sequel II System”, inclusive of SMRT Cell 8M as well as chemistry, instrument control software and SMRT Link software package. This product is expected to reduce the time required for project outputs while also significantly reducing the costs of operations
  • In August 2018, 10x Genomics announced that they had acquired “Epinomics” which will subsequently help expand the technological base of 10x Genomics which will be integrated into their “Chromium Single Cell ATC Solution”. This acquisition is a strategic decision based on the focus of the company on enhancing the scientific capabilities and provide their customers with the most advanced biological technologies

Market Drivers

  • Increasing utilization of epigenetics technology due to the growing prevalence of target areas of application
  • Focus of authorities and organizations to develop and implement advanced technologies with innovative offerings for the consumers; this factor is expected to propel the growth of the market
  • Increasing areas of application of epigenetics technology is another factor boosting the market growth
  • Rising volume of geriatric population worldwide will also uplift the growth of the market

Market Restraints

    • Large levels of financial expenditure required for the acquisition and utilization of epigenetics-based instruments; this factor is expected act as a restraint in the growth of this market
    • Presence of various regulatory demands and compliances for the commercialization of epigenetics-based products and services will also impede the market growth
    • Dearth of proficient individuals for appropriate utilization of epigenetics technology acts as a restricting factor

Inquiry For Customize Report With Discount at :   https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-epigenetics-based-instruments-market

Segmentation: Global Epigenetics-Based Instruments Market

By Product

  • Mass Spectrometers
  • Next-Generation Sequencing (NGS)
  • Quantitative Polymerase Chain Reactions (qPCRs)
  • Sonicators
  • Others

By Technology

  • DNA Methylation
  • Histone Methylation
  • Histone Acetylation
  • Large Non-Coding RNA
  • MicroRNA Modification
  • Chromatin Structures

By Application

  • Oncology
    • Solid Tumors
    • Liquid Tumors
  • Non-Oncology
    • Inflammatory Diseases
    • Metabolic Diseases
    • Infectious Diseases
    • Cardiovascular Diseases
  • Development Biology
  • Drug Discovery
  • Others

By End-Users

  • Academic & Research Institutes
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Contract Research Organizations (CROs)

By Geography

      • North America
      • Europe
      • Asia-Pacific
      • South America
      • Middle East and Africa

Get Full Table Of content @   https://www.databridgemarketresearch.com/toc/?dbmr=global-epigenetics-based-instruments-market

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like Asia, United States, and Europe.

Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]

Tags

>

Related Articles

Back to top button